DSP |
Viant Technology Inc. |
2024 |
Q4 |
2025-03-03 |
|
OKTA |
Okta, Inc. |
2025 |
Q4 |
2025-03-03 |
|
NMRA |
Neumora Therapeutics, Inc. Common Stock |
2024 |
Q4 |
2025-03-03 |
|
OCUL |
Ocular Therapeutix, Inc. |
2024 |
Q4 |
2025-03-03 |
|
NABL |
N-able, Inc. |
2024 |
Q4 |
2025-03-03 |
|
STXS |
Stereotaxis, Inc. |
2024 |
Q4 |
2025-03-03 |
|
RC |
Ready Capital Corporation |
2024 |
Q4 |
2025-03-03 |
|
GCT |
GigaCloud Technology Inc. |
2024 |
Q4 |
2025-03-03 |
|
EKSO |
Ekso Bionics Holdings, Inc. |
2024 |
Q4 |
2025-03-03 |
|
MRCC |
Monroe Capital Corporation |
2024 |
Q4 |
2025-03-03 |
|
EBS |
Emergent BioSolutions Inc. |
2024 |
Q4 |
2025-03-03 |
|
RILY |
B. Riley Financial, Inc. - 6.50 |
2024 |
Q4 |
2025-03-03 |
|
FTRE |
Fortrea Holdings Inc. |
2024 |
Q4 |
2025-03-03 |
|
TDUP |
ThredUp Inc. |
2024 |
Q4 |
2025-03-03 |
|
BDSX |
Biodesix, Inc. |
2024 |
Q4 |
2025-03-03 |
|
NOMD |
Nomad Foods Limited |
2024 |
Q4 |
2025-03-03 |
|
SGRY |
Surgery Partners, Inc. |
2024 |
Q4 |
2025-03-03 |
|
SMR |
NuScale Power Corporation |
2024 |
Q4 |
2025-03-03 |
|
CRC |
California Resources Corporation |
2024 |
Q4 |
2025-03-03 |
|
MRSN |
Mersana Therapeutics, Inc. |
2024 |
Q4 |
2025-03-03 |
|
HSII |
Heidrick & Struggles International, Inc. |
2024 |
Q4 |
2025-03-03 |
|
RPAY |
Repay Holdings Corporation |
2024 |
Q4 |
2025-03-03 |
|
SNDX |
Syndax Pharmaceuticals, Inc. |
2024 |
Q4 |
2025-03-03 |
|
AVDL |
Avadel Pharmaceuticals plc |
2024 |
Q4 |
2025-03-03 |
|
ADMA |
ADMA Biologics, Inc. |
2024 |
Q4 |
2025-03-03 |
|